Inflammatory Monocytes Promote Perineural Invasion via CCL2-Mediated Recruitment and Cathepsin B Expression
Richard L Bakst1, Huizhong Xiong2, Chun-Hao Chen3
1Department of Radiation Oncology, Mount Sinai School of Medicine, New York, New York.
Cancer Research
|September 28, 2017
Summary
Inflammatory monocytes (IM) promote perineural invasion (PNI) by entering nerves and releasing cathepsin B. Blocking this process, driven by CCL2 and CCR2 signaling, may offer new therapies for PNI and reduce tumor recurrence.
Area of Science:
- Oncology
- Immunology
- Neuroscience
Background:
- Perineural invasion (PNI) is a significant predictor of poor patient outcomes in various cancers.
- The tumor microenvironment's role in facilitating PNI, particularly the involvement of peripheral nerves and immune cells, remains incompletely understood.
Purpose of the Study:
- To elucidate the mechanisms by which inflammatory monocytes (IM) contribute to PNI.
- To identify key molecular signaling pathways involved in IM recruitment and function during PNI.
Main Methods:
- Utilized adoptive transfer experiments with genetically engineered mouse models.
- Investigated the roles of CCL2, CCR2, and cathepsin B in PNI.
- Performed correlative studies on human cancer specimens.
Main Results:
- CCR2-expressing IM are recruited to sites of PNI and differentiate into macrophages.
- Schwann cell-derived CCL2 drives IM recruitment via CCR2 signaling, potentiating nerve invasion through cathepsin B.
- Inhibition of CCL2-CCR2 signaling or cathepsin B significantly reduced PNI in vivo.
- Cathepsin B-producing macrophages were found in nerves of human specimens with PNI, correlating with increased local tumor recurrence.
Conclusions:
- PNI involves the corruption of nerve repair pathways by cancer cells and inflammatory monocytes.
- Targeting IM recruitment (CCL2-CCR2 axis) and function (cathepsin B) presents a potential therapeutic strategy for PNI.
Related Concept Videos
Cancer Cell Migration through Invadopodia
3.3K
Invadosome is a broad category of cell surface structures with proteolytic activity that degrades the extracellular matrix (ECM). Invadosomes are present in normal cell types, including macrophages, endothelial cells, and neurons, as well as tumor cells. Although the macrophage podosomes and tumor cell invadopodia are classified as invadosomes, they have different structures, molecular pathways, and functions. Podosomes are short structures that last for a few minutes. However,...
3.3K
Differentiation of Common Myeloid Progenitor Cells
4.1K
Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
4.1K
Inflammation
62.7K
Overview
62.7K
Metastasis
6.7K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
6.7K


